Compile Data Set for Download or QSAR
Report error Found 389 Enz. Inhib. hit(s) with all data for entry = 11321
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607107(US11685745, Example 64)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607106(US11685745, Example 51)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607105(US11685745, Example 43)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607104(US11685745, Example 37)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607111(US11685745, Example 189)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607110(US11685745, Example 176)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607109(US11685745, Example 123)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607108(US11685745, Example 79)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607115(US11685745, Example 334)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607114(US11685745, Example 332)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607112(US11685745, Example 225)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607119(US11685745, Example 427)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607118(US11685745, Example 378)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607116(US11685745, Example 336)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607123(US11685745, Example 557)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607122(US11685745, Example 545)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607121(US11685745, Example 492)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607124(US11685745, Example 581 | US11685745, Example 576)
Affinity DataIC50: 10nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607131(US11685745, Example 16)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607130(US11685745, Example 15)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607129(US11685745, Example 7)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607128(US11685745, Example 6)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607135(US11685745, Example 21)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607134(US11685745, Example 20)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607133(US11685745, Example 19)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607132(US11685745, Example 17)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607139(US11685745, Example 28)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607138(US11685745, Example 27)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607137(US11685745, Example 26)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607136(US11685745, Example 22)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607143(US11685745, Example 35)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607142(US11685745, Example 34)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607141(US11685745, Example 31)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607140(US11685745, Example 30)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607127(US11685745, Example 5)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607126(US11685745, Example 4)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607125(US11685745, Example 2)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607163(US11685745, Example 60)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607162(US11685745, Example 58)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607161(US11685745, Example 57)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607160(US11685745, Example 56)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607167(US11685745, Example 66)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607166(US11685745, Example 65)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607165(US11685745, Example 62)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607164(US11685745, Example 61)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607171(US11685745, Example 74)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607170(US11685745, Example 73)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607169(US11685745, Example 71)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607168(US11685745, Example 67)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 7B(Human)
Dart Neuroscience

US Patent
LigandPNGBDBM607175(US11685745, Example 78)
Affinity DataIC50: 55nMAssay Description:PDE7 inhibition was determined by an IMAP TR-FRET assay using PDE7B. The IMAP TR-FRET PDE assay was optimized for concentration of enzyme, FAM-cAMP s...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2023
Entry Details
US Patent

Displayed 1 to 50 (of 389 total ) | Next | Last >>
Jump to: